128 related articles for article (PubMed ID: 15969447)
1. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats.
Diedrichs-Möhring M; Wildner G
Immunobiology; 2005; 209(10):711-7. PubMed ID: 15969447
[TBL] [Abstract][Full Text] [Related]
2. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin.
Wildner G; Diedrichs-Möhring M; Thurau SR
Eur J Immunol; 2002 Jan; 32(1):299-306. PubMed ID: 11782021
[TBL] [Abstract][Full Text] [Related]
3. Gamma-delta T cells as orally induced suppressor cells in rats: in vitro characterization.
Wildner G; Thurau SR; Diedrichs-Möhring M
Ann N Y Acad Sci; 2004 Dec; 1029():416-21. PubMed ID: 15681796
[TBL] [Abstract][Full Text] [Related]
4. Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo.
Wildner G; Diedrichs-Möhring M
Int Immunol; 2003 Aug; 15(8):927-35. PubMed ID: 12882830
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
Wildner G; Thurau SR
Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
[TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.
Thurau SR; Diedrichs-Möhring M; Fricke H; Arbogast S; Wildner G
Immunol Lett; 1997 Jun; 57(1-3):193-201. PubMed ID: 9232451
[TBL] [Abstract][Full Text] [Related]
7. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
[TBL] [Abstract][Full Text] [Related]
8. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease.
Huber A; Diedrichs-Möhring M; Wildner G
Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538
[TBL] [Abstract][Full Text] [Related]
9. Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?
Lahesmaa R; Skurnik M; Toivanen P
Immunol Res; 1993; 12(2):193-208. PubMed ID: 7504716
[TBL] [Abstract][Full Text] [Related]
10. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide.
Singh VK; Kalra HK; Yamaki K; Shinohara T
Cell Immunol; 1992 Jan; 139(1):81-90. PubMed ID: 1728971
[TBL] [Abstract][Full Text] [Related]
12. Rat models of autoimmune uveitis.
Wildner G; Diedrichs-Mohring M; Thurau SR
Ophthalmic Res; 2008; 40(3-4):141-4. PubMed ID: 18421228
[TBL] [Abstract][Full Text] [Related]
13. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J
J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516
[TBL] [Abstract][Full Text] [Related]
14. A synthetic dimeric HLA class I peptide inhibits T cell activity in vitro and prolongs allogeneic heart graft survival in a mouse model.
Woo J; Gao L; Cornejo MC; Buelow R
Transplantation; 1995 Nov; 60(10):1156-63. PubMed ID: 7482725
[TBL] [Abstract][Full Text] [Related]
15. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis.
Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G
Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581
[TBL] [Abstract][Full Text] [Related]
16. The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models.
Diedrichs-Möhring M; Kaufmann U; Wildner G
Prog Retin Eye Res; 2018 Jul; 65():107-126. PubMed ID: 29496590
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides.
Vrabec TR; Gregerson DS; Dua HS; Donoso LA
Autoimmunity; 1992; 12(3):175-84. PubMed ID: 1343765
[TBL] [Abstract][Full Text] [Related]
18. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.
Breban M; Fernández-Sueiro JL; Richardson JA; Hadavand RR; Maika SD; Hammer RE; Taurog JD
J Immunol; 1996 Jan; 156(2):794-803. PubMed ID: 8543835
[TBL] [Abstract][Full Text] [Related]
19. Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis.
Wildner G; Hünig T; Thurau SR
Eur J Immunol; 1996 Sep; 26(9):2140-8. PubMed ID: 8814259
[TBL] [Abstract][Full Text] [Related]
20. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia.
Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
J Immunol; 2001 Sep; 167(6):3375-82. PubMed ID: 11544328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
